IL95124A0 - Pharmaceutical compositions containing spirocyclic compounds,certain such novel compounds and their preparation - Google Patents
Pharmaceutical compositions containing spirocyclic compounds,certain such novel compounds and their preparationInfo
- Publication number
- IL95124A0 IL95124A0 IL95124A IL9512490A IL95124A0 IL 95124 A0 IL95124 A0 IL 95124A0 IL 95124 A IL95124 A IL 95124A IL 9512490 A IL9512490 A IL 9512490A IL 95124 A0 IL95124 A0 IL 95124A0
- Authority
- IL
- Israel
- Prior art keywords
- compounds
- preparation
- certain
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/20—Spiro-condensed ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898917069A GB8917069D0 (en) | 1989-07-26 | 1989-07-26 | Therapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL95124A0 true IL95124A0 (en) | 1991-06-10 |
Family
ID=10660644
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL95124A IL95124A0 (en) | 1989-07-26 | 1990-07-19 | Pharmaceutical compositions containing spirocyclic compounds,certain such novel compounds and their preparation |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0414289B1 (fr) |
| JP (1) | JPH03184959A (fr) |
| KR (1) | KR910002444A (fr) |
| AT (1) | ATE101854T1 (fr) |
| AU (1) | AU628612B2 (fr) |
| CA (1) | CA2021736A1 (fr) |
| DE (1) | DE69006799T2 (fr) |
| DK (1) | DK0414289T3 (fr) |
| ES (1) | ES2062303T3 (fr) |
| FI (1) | FI903728A0 (fr) |
| GB (1) | GB8917069D0 (fr) |
| IE (1) | IE902706A1 (fr) |
| IL (1) | IL95124A0 (fr) |
| NO (1) | NO903315L (fr) |
| NZ (1) | NZ234557A (fr) |
| PT (1) | PT94806A (fr) |
| ZA (1) | ZA905841B (fr) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0445974A3 (en) * | 1990-03-05 | 1992-04-29 | Merck Sharp & Dohme Ltd. | Spirocyclic antipsychotic agents |
| NZ243065A (en) * | 1991-06-13 | 1995-07-26 | Lundbeck & Co As H | Piperidine derivatives and pharmaceutical compositions |
| DK78692D0 (da) * | 1992-06-12 | 1992-06-12 | Lundbeck & Co As H | Dimere piperidin- og piperazinderivater |
| CA2143117A1 (fr) * | 1992-10-07 | 1994-04-14 | Ben E. Evans | Antagonistes du recepteur de l'oxytocine de la tocolyse |
| US5670509A (en) * | 1993-09-27 | 1997-09-23 | Merck & Co., Inc. | Tocolytic oxytocin receptor antagonists |
| AU2223495A (en) * | 1994-04-15 | 1995-11-10 | Yamanouchi Pharmaceutical Co., Ltd. | Spiro compound and medicinal composition thereof |
| SK17512001A3 (sk) * | 1999-06-07 | 2002-11-06 | Warner-Lambert Company | Tricyklické analgetiká |
| US7045527B2 (en) | 2002-09-24 | 2006-05-16 | Amgen Inc. | Piperidine derivatives |
| BRPI0508098A (pt) | 2004-02-27 | 2007-07-17 | Amgen Inc | compostos, composições farmacêuticas e métodos para uso no tratamento de distúrbios metabólicos |
| JP2008510728A (ja) | 2004-08-19 | 2008-04-10 | バーテックス ファーマシューティカルズ インコーポレイテッド | ムスカリン受容体のモジュレーター |
| US7786141B2 (en) | 2004-08-19 | 2010-08-31 | Vertex Pharmaceuticals Incorporated | Dihydrospiroindene modulators of muscarinic receptors |
| AU2005276590B2 (en) | 2004-08-27 | 2011-05-19 | Laboratorios Del Dr. Esteve, S.A. | Sigma receptor inhibitors |
| KR20070046194A (ko) | 2004-08-27 | 2007-05-02 | 라보라토리오스 델 드라. 에스테브.에스.에이. | 시그마 수용체 저해제 |
| EP1634873A1 (fr) | 2004-08-27 | 2006-03-15 | Laboratorios Del Dr. Esteve, S.A. | Inhibiteurs des récepteurs sigma |
| DK1781618T3 (da) | 2004-08-27 | 2012-10-29 | Esteve Labor Dr | Sigma-receptorinhibitorer |
| WO2006058303A2 (fr) | 2004-11-29 | 2006-06-01 | Vertex Pharmaceuticals Incorporated | Modulateurs des recepteurs muscariniques |
| EP1924546A1 (fr) | 2005-09-14 | 2008-05-28 | Amgen, Inc | Acides propanoïques 3-substitués par un groupement 4-hydroxyphényle à conformation contrainte pouvant être employés dans le traitement de troubles métaboliques |
| WO2007076070A2 (fr) | 2005-12-22 | 2007-07-05 | Vertex Pharmaceuticals Incorporated | Modulateurs de recepteurs muscariniques |
| KR20080094964A (ko) * | 2006-02-22 | 2008-10-27 | 버텍스 파마슈티칼스 인코포레이티드 | 무스카린성 수용체의 조절제 |
| KR20080098070A (ko) | 2006-02-22 | 2008-11-06 | 버텍스 파마슈티칼스 인코포레이티드 | 무스카린성 수용체의 조절제로서의 스피로 축합된 피페리딘 |
| EP1829875A1 (fr) | 2006-03-01 | 2007-09-05 | Laboratorios Del Dr. Esteve, S.A. | Dérivés de pyrazole comme inhibiteurs de récepteur Sigma |
| JP2009528315A (ja) | 2006-03-01 | 2009-08-06 | ラボラトリオス・デル・ドクトル・エステベ・ソシエダッド・アノニマ | シグマ受容体阻害剤としてのピラゾール誘導体 |
| EP1829866A1 (fr) | 2006-03-02 | 2007-09-05 | Laboratorios Del Dr. Esteve, S.A. | Inhibiteurs des récepteurs sigma |
| EP1829867A1 (fr) | 2006-03-03 | 2007-09-05 | Laboratorios Del Dr. Esteve, S.A. | Composés d'imidazole ayant une acitivité pharmaceutique vis-à-vis le recepteur sigma |
| JP2009542670A (ja) | 2006-06-29 | 2009-12-03 | バーテックス ファーマシューティカルズ インコーポレイテッド | ムスカリン受容体の調節剤 |
| AU2007284548A1 (en) | 2006-08-15 | 2008-02-21 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
| JP2010501561A (ja) | 2006-08-18 | 2010-01-21 | バーテックス ファーマシューティカルズ インコーポレイテッド | ムスカリン受容体の調節剤 |
| US7714008B2 (en) | 2006-09-07 | 2010-05-11 | Amgen Inc. | Heterocyclic GPR40 modulators |
| EP2061760A1 (fr) | 2006-09-07 | 2009-05-27 | Amgen, Inc | Composés benzo-fusionnés destinés à être utilisés dans le traitement de troubles métaboliques |
| WO2008130514A1 (fr) | 2007-04-16 | 2008-10-30 | Amgen Inc. | Modulateurs de gpr40 des acides biphényle phénoxy, thiophényle et aminophénylpropanoïque substitués |
| US7973162B2 (en) | 2007-10-03 | 2011-07-05 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
| WO2009048527A1 (fr) | 2007-10-10 | 2009-04-16 | Amgen Inc. | Modulateurs du gpr40 à biphényle substitué |
| WO2009111056A1 (fr) | 2008-03-06 | 2009-09-11 | Amgen Inc. | Dérivés d'acide carboxylique conformationnellement dépendants, utiles dans le traitement de troubles du métabolisme |
| EP2116539A1 (fr) | 2008-04-25 | 2009-11-11 | Laboratorios Del. Dr. Esteve, S.A. | 1-aryl-3-aminoalkoxy-pyrazoles en tant que ligands améliorant les effets analgésiques des opioïdes et réduisant leur dépendance |
| US8748462B2 (en) | 2008-10-15 | 2014-06-10 | Amgen Inc. | Spirocyclic GPR40 modulators |
| EP2353598A1 (fr) | 2010-02-04 | 2011-08-10 | Laboratorios Del. Dr. Esteve, S.A. | Ligands sigma pour utilisation dans la prévention et/ou le traitement de la douleur post-opératoire |
| EP2353591A1 (fr) | 2010-02-04 | 2011-08-10 | Laboratorios Del. Dr. Esteve, S.A. | Ligands sigma pour la potentialisation de l'effet analgésique d'opioïdes et d'opiacés dans la douleur post-opératoire et en atténuant la dépendance |
| EP2388005A1 (fr) | 2010-05-21 | 2011-11-23 | Laboratorios Del. Dr. Esteve, S.A. | Ligands sigma pour la prévention et/ou le traitement du vomissement induit par la chimiothérapie ou la radiothérapie |
| EP2395003A1 (fr) | 2010-05-27 | 2011-12-14 | Laboratorios Del. Dr. Esteve, S.A. | Composés pyrazoliques en tant qu'inhibiteurs du récepteur sigma |
| EP2415471A1 (fr) | 2010-08-03 | 2012-02-08 | Laboratorios Del. Dr. Esteve, S.A. | Utilisation de ligands sigma dans l'hyperalgie induite par opioïdes |
| EP2524694A1 (fr) | 2011-05-19 | 2012-11-21 | Laboratorios Del. Dr. Esteve, S.A. | Utilisation de ligands sigma dans la douleur liée au diabète de type 2 |
| EP3082782A1 (fr) | 2013-12-17 | 2016-10-26 | Laboratorios Del. Dr. Esteve, S.A. | Combinaisons d'inhibiteurs de la recapture de sérotonine-norépinéphrine (snri) et de ligands des récepteurs sigma |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3985888A (en) * | 1969-07-24 | 1976-10-12 | Richardson-Merrell Inc. | Methods of inducing sedation using certain spiroalkanone-imides |
-
1989
- 1989-07-26 GB GB898917069A patent/GB8917069D0/en active Pending
-
1990
- 1990-07-18 NZ NZ234557A patent/NZ234557A/xx unknown
- 1990-07-19 IL IL95124A patent/IL95124A0/xx unknown
- 1990-07-23 CA CA002021736A patent/CA2021736A1/fr not_active Abandoned
- 1990-07-23 EP EP90202012A patent/EP0414289B1/fr not_active Expired - Lifetime
- 1990-07-23 ES ES90202012T patent/ES2062303T3/es not_active Expired - Lifetime
- 1990-07-23 DK DK90202012.2T patent/DK0414289T3/da active
- 1990-07-23 DE DE69006799T patent/DE69006799T2/de not_active Expired - Fee Related
- 1990-07-23 AT AT90202012T patent/ATE101854T1/de not_active IP Right Cessation
- 1990-07-24 PT PT94806A patent/PT94806A/pt not_active Application Discontinuation
- 1990-07-25 AU AU59844/90A patent/AU628612B2/en not_active Ceased
- 1990-07-25 NO NO90903315A patent/NO903315L/no unknown
- 1990-07-25 IE IE270690A patent/IE902706A1/en unknown
- 1990-07-25 FI FI903728A patent/FI903728A0/fi not_active IP Right Cessation
- 1990-07-25 ZA ZA905841A patent/ZA905841B/xx unknown
- 1990-07-26 KR KR1019900011368A patent/KR910002444A/ko not_active Application Discontinuation
- 1990-07-26 JP JP2196403A patent/JPH03184959A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| NZ234557A (en) | 1992-12-23 |
| FI903728A0 (fi) | 1990-07-25 |
| JPH03184959A (ja) | 1991-08-12 |
| KR910002444A (ko) | 1991-02-25 |
| ZA905841B (en) | 1991-06-26 |
| DE69006799T2 (de) | 1994-08-11 |
| EP0414289B1 (fr) | 1994-02-23 |
| ATE101854T1 (de) | 1994-03-15 |
| NO903315L (no) | 1991-01-28 |
| PT94806A (pt) | 1991-03-20 |
| DK0414289T3 (da) | 1994-04-11 |
| ES2062303T3 (es) | 1994-12-16 |
| EP0414289A1 (fr) | 1991-02-27 |
| GB8917069D0 (en) | 1989-09-13 |
| DE69006799D1 (de) | 1994-03-31 |
| AU628612B2 (en) | 1992-09-17 |
| CA2021736A1 (fr) | 1991-01-27 |
| AU5984490A (en) | 1991-01-31 |
| NO903315D0 (no) | 1990-07-25 |
| IE902706A1 (en) | 1991-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL95124A0 (en) | Pharmaceutical compositions containing spirocyclic compounds,certain such novel compounds and their preparation | |
| HU0301601D0 (en) | Bis(n-substituted)-staurosporine derivatives, their use and pharmaceutical composition containing thereof | |
| IL95385A0 (en) | Macrocyclic compounds,their production and pharmaceutical compositions containing them | |
| HUT48248A (en) | Process for producing 3,7-diazabicyclo/3,3,1/-nonan derivatives and pharmaceutical compositions containing them | |
| HUT61554A (en) | Process for producing 2,8-dioxabicyclo/3.2.1/octane derivatives and pharmaceutical compositions comprising same | |
| NZ230041A (en) | Selectively o-acylated glycosaminoglycans; their preparation and pharmaceutical compositions containing them | |
| GR3015634T3 (en) | Process for the preparation of micronised biodegradable particles. | |
| NZ219386A (en) | Naphtho(1,2-b)-1,4-thiazepinone derivatives and pharmaceutical compositions | |
| EP0410535A3 (fr) | Dérivés d'octahydrobenzisoquinoline comme agents antipsychotiques | |
| IL106289A0 (en) | Phospholipid derivatives, their preparation and pharmaceutical compositions containing them | |
| IL90865A0 (en) | Pharmaceutical compositions containing 1,4-diazepine derivatives,certain such novel compounds and their preparation | |
| HUT45261A (en) | Process for producing 7-oxo-4-thia-1-aza-bicyclo/3.2.0/-hept-2-ene derivatives and pharmaceutical compositions containing them | |
| GR3005838T3 (fr) | ||
| IL92759A0 (en) | Pharmaceutical compositions containing 1,2,3,4-tetrahydroacridine derivatives and certain such novel compounds | |
| HUP9600928A3 (en) | Use of spiro[2h-1-benzopyran-2,4'-piperidin]-4(3h)-one derivatives for the preparation of pharmaceutical compositions treating dementia, novel derivatives and process for their preparation | |
| HUT54674A (en) | Process for producing 3,18-dihydroxy-9,13-epoxy-labdane derivatives and pharmaceutical compositions containing them | |
| BG52066B2 (en) | Antitumour preparation | |
| NZ230418A (en) | Substituted 4-azatricyclo (22.3.1.0 4,9 ) octacos-18-ene derivatives, preparation from streptomyces culture, and pharmaceutical compositions | |
| IL86785A0 (en) | 1,3-dioxane and tetrahydropyran derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| GB8918758D0 (en) | Substituted 4-azatricyclo(22.3.1.0.4.9)octacos-18-ene derivatives,their preparation and pharmaceutical compositions containing them | |
| IE870538L (en) | Treating emesis caused by anticancer drugs | |
| IE870539L (en) | Treating emesis caused by anticancer drugs | |
| ZA818972B (en) | Substituted tetrahydro-1,2,4-oxadiazin-5-one derivates having anticonvulsive activity,process for their preparation and pharmaceutical compositions containing them |